Immune checkpoint inhibitor topics

Immune checkpoint inhibitors are a new immunotherapy treatment option for advanced non–small-cell lung cancer (NSCLC). Learn more about immune checkpoint inhibitors.

yellow unaunahi on orange background
Immune checkpoint inhibitors for advanced non–small-cell lung cancer
Keytruda (also called pembrolizumab)
Tecentriq (also called atezolizumab)
Imfinzi (also called durvalumab)